Celularity Inc. Files 2024 10-K

Ticker: CELUW · Form: 10-K · Filed: May 8, 2025 · CIK: 1752828

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Celularity filed its 2024 10-K. Financials and operations for the year ending Dec 31, 2024, are detailed.

AI Summary

Celularity Inc. filed its 2024 10-K on May 8, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly GX Acquisition Corp., is involved in pharmaceutical preparations. Key financial details and operational aspects for the fiscal year 2024 are presented in this filing.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Celularity Inc.'s financial performance, strategic initiatives, and risk factors for the fiscal year 2024, enabling informed decision-making.

Risk Assessment

Risk Level: medium — As a pharmaceutical preparations company, Celularity faces inherent risks related to research and development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What was Celularity Inc.'s former name?

Celularity Inc.'s former name was GX Acquisition Corp., with a date of name change on 20180912.

What is the Central Index Key (CIK) for Celularity Inc.?

The Central Index Key for Celularity Inc. is 0001752828.

What is the Standard Industrial Classification (SIC) code for Celularity Inc.?

The SIC code for Celularity Inc. is 2834, which corresponds to Pharmaceutical Preparations.

On what date was this 10-K filing submitted?

This 10-K filing was submitted on 20250508.

What fiscal year does this 10-K report cover?

This 10-K report covers the fiscal year ending on 20241231.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on May 8, 2025 regarding Celularity Inc (CELUW).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing